US$ 26.66
ddp4 inhibitor and glp 1 agonist The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect GLP-1 Receptor Agonists in Chronic
Description
Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study

2.3% with placebo) [36]

Chen, T., Cao, Q., Wang, Y
The GIP component is hypothesized to provide an additional mechanism to buffer against the hyperglycemic effects of glucagon [940], thus permitting triple agonists of higher potency at the glucagon receptor that in theory could drive more body weight loss

2019;33(10) doi: 10.1002/jbt.22388
